Cumberland Pharmaceuticals (CPIX) Total Debt (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Total Debt across 16 years of filings, most recently posting $5.2 million for Q1 2026.

• Total Debt for Q1 2026 came in at $5.2 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 million (changed 0.0% YoY), and the FY2025 annual result was $5.2 million, down 65.69% from the prior year.
• Total Debt came in at $5.2 million for Q1 2026 at Cumberland Pharmaceuticals, roughly flat from $5.2 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $20.0 million in Q1 2022 to a low of $5.2 million in Q1 2025.
• The 5-year median for Total Debt is $15.3 million (2024), against an average of $12.8 million.
• Across the five-year window, Total Debt surged 35.71% in 2022 and tumbled 67.43% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Total Debt stood at $16.2 million in 2022, then dropped by 21.09% to $12.8 million in 2023, then increased by 19.49% to $15.3 million in 2024, then plunged by 65.69% to $5.2 million in 2025, then changed by 0.0% to $5.2 million in 2026.
• The last three Total Debt figures came in at $5.2 million (Q1 2026), $5.2 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.